» Articles » PMID: 28507865

Reconstitution of Human Keloids in Mouse Skin

Overview
Specialty General Surgery
Date 2017 May 17
PMID 28507865
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Keloids are a dermal fibroproliferative scar of unknown etiology. There is no good animal model for the study of keloids, which hinders the development and assessment of treatments for keloids.

Methods: Human keratinocytes and dermal fibroblasts were isolated from 3 human skin tissues: normal skin, white scars, and keloids. A mixed-cell slurry containing keratinocytes and dermal fibroblasts was poured into a double chamber implanted on the back of NOD/Shi-scid/IL-2Rγnull mice. After 12 weeks, the recipient mice had developed reconstituted human skin tissues on their backs. These were harvested for histological studies.

Results: Macroscopically, the reconstituted skins derived from both normal skin and white scars were similar to normal skin and white scars in humans, respectively. Keloid-derived reconstituted skins exhibited keloid-like hypertrophic nodules. Histological findings and immunohistochemical staining confirmed that the reconstituted skin tissues were of human origin and the keloid-derived reconstituted skin had the typical features of human keloids such as a hypertrophic dermal nodule, collagen type composition, orientation of collagen fibers, and versican expression.

Conclusion: The mouse model with humanized keloid tissue presented here should be a useful tool for future keloid research.

Citing Articles

Deciphering the single-cell transcriptome network in keloids with intra-lesional injection of triamcinolone acetonide combined with 5-fluorouracil.

Xia Y, Wang Y, Hao Y, Shan M, Liu H, Liang Z Front Immunol. 2023; 14:1106289.

PMID: 37275903 PMC: 10235510. DOI: 10.3389/fimmu.2023.1106289.


Human In Vitro Skin Models for Wound Healing and Wound Healing Disorders.

Hofmann E, Fink J, Pignet A, Schwarz A, Schellnegger M, Nischwitz S Biomedicines. 2023; 11(4).

PMID: 37189674 PMC: 10135654. DOI: 10.3390/biomedicines11041056.


Inhibition of growth of Asian keloid cells with human umbilical cord Wharton's jelly stem cell-conditioned medium.

Arjunan S, Gan S, Choolani M, Raj V, Lim J, Biswas A Stem Cell Res Ther. 2020; 11(1):78.

PMID: 32085797 PMC: 7035736. DOI: 10.1186/s13287-020-01609-7.


Animal Models for Studies of Keloid Scarring.

Supp D Adv Wound Care (New Rochelle). 2019; 8(2):77-89.

PMID: 31832272 PMC: 6906757. DOI: 10.1089/wound.2018.0828.


Inhibition as a Novel Therapeutic Target for Keloid Disease.

Park T, Kim C, Choi J, Park Y, Chong Y, Park M Adv Wound Care (New Rochelle). 2019; 8(5):186-194.

PMID: 31119062 PMC: 6529855. DOI: 10.1089/wound.2018.0910.

References
1.
Hillmer M, MacLeod S . Experimental keloid scar models: a review of methodological issues. J Cutan Med Surg. 2002; 6(4):354-9. DOI: 10.1007/s10227-001-0121-y. View

2.
LeBleu V, Taduri G, OConnell J, Teng Y, Cooke V, Woda C . Origin and function of myofibroblasts in kidney fibrosis. Nat Med. 2013; 19(8):1047-53. PMC: 4067127. DOI: 10.1038/nm.3218. View

3.
Ito M, Hiramatsu H, Kobayashi K, Suzue K, Kawahata M, Hioki K . NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood. 2002; 100(9):3175-82. DOI: 10.1182/blood-2001-12-0207. View

4.
Polo M, Kim Y, Kucukcelebi A, Hayward P, Ko F, ROBSON M . An in vivo model of human proliferative scar. J Surg Res. 1998; 74(2):187-95. DOI: 10.1006/jsre.1997.5251. View

5.
Yagi Y, Muroga E, Naitoh M, Isogai Z, Matsui S, Ikehara S . An ex vivo model employing keloid-derived cell-seeded collagen sponges for therapy development. J Invest Dermatol. 2012; 133(2):386-93. DOI: 10.1038/jid.2012.314. View